0

Takaki Shimura

Sosei BME research Lab, Japan

Title: A Neuropsychological Test Named CKPT Available on Pre-clinical Stage of Dementia

Abstract

Since a neuropsychological test named CWPT (Color Words Pick-out test) was presented on 2018 at the 24th International Conference on Neuroscience and Neurochemistry, many advancements have been done. In this presentation, diagnostic criteria using CKPT (Color Kanji Pick-out Test: Japanese version of CWPT), application of CKPT to healthy people, examining the normality of 15 year’s large scale CKPT results are introduced. As recent new examinations using CKPT, a health care activity for prevention of dementia, support activity for companies who employ the aged people will be introduced, too. Finally, tools to perform CWPT are showed for researchers who have interest in trying it in their country.

Biography

Since 2009, Takaki Shimura founded Biomedical Research Lab. and daycare service houses to apply his inventions to the elderly with dementia in Sosei Ltd.. Since 2000, he worked at Tokai University as a Professor, researching mainly BME on dementia. From 1965 to 2000, he worked in R&D field of Fujitsu Ltd. and Fujitsu Laboratories Ltd., developing Ultrasound imaging, X-ray imaging by flat panel detector, Remote health care system by TV etc. (2000-1979) and Fault location diagnosis method on digital circuit, Shinkansen passenger automatic guidance system and Laser printer (1979-1965). He graduated Tokai University majoring Atomic Industry in 1965. He got PhD degree from Tokyo University in 1995 and Engineering fellow of the Japan Society of Ultrasound in Medicine in 2005. He is an honor director of Japan Society for Early Stage of Dementia and the chairman of BME on Dementia Group of the Japanese Society for Medical and Biological Engineering. My speciality is Biomedical engineering on dementia, including detection and rehabilitation of dementia. For MCI and Preclinical Stage of Dementia, a neuropsychological test named CWPT (Color Words Pick-out Test) is devised and is just in use in Japan, which is attracting international attention as a test that can detect changes in brain function before the onset of dementia. For Dementia, We have a track record of 13 years of dementia care, and have established a dementia care method that reduces the MMSE by only a few points in 10 years.